Sandoz Losartan Potassium & Ezetimibe Drug Recall [US]

Sandoz Losartan Potassium & Ezetimibe Drug Recall [US]

  Click to enlarge

US FlagUS/Washington: Sandoz Inc., a Princeton, New Jersey establishment, recalls an estimated 636,000 Losartan Potassium Prescription Drug and Ezetimibe Prescription Drug Bottles due to suspected failure to meet child-resistant closure requirements as required by the US Poison Prevention Packaging Act and consequential risk of choking, ingestion and poisoning, all serious health and safety hazards.

CPSC: http://ht.ly/2wC230proqE

Direct link: https://www.cpsc.gov/Recalls/2019/Sandoz-Recalls-Losartan-Potassium-and-Ezetimibe-Prescription-Drug-Bottles-Due-to-Failure-to-Meet-ChildResistant-Closure-Requirements

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves Bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain identified batch/lot numbers.

Continue reading

Sandoz & Novartis Drug Blister Package Recall [US]

US FlagUS/Washington: Sandoz and Novartis Drug Blister Package Recall [US]Sandoz and Novartis recall an estimated 470,000 Prescription Drug Blister Packages due to suspected failure to meet child-resistant closure requirements as required by the US Poison Prevention Packaging Act and consequential risk of choking, ingestion and poisoning, all serious health and safety hazards.

CPSC: http://ht.ly/qXyk30kR2SM

Direct link: https://www.cpsc.gov/Recalls/2018/Sandoz-and-Novartis-Recall-Prescription-Drug-Blister-Packages-Due-to-Failure-to-Meet-Child-Resistant-Closure-Requirements

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports this recall involves certain Blister Packages of various Prescription Drugs branded by Novartis and Sandoz. The Drugs are packaged with three (3) to ten (10) tablets per blister card.

Continue reading

Novartis Triaminic, Theraflu Recall

US/Washington: Novartis recalls various Triaminic Syrups and Theraflu Warming Relief Syrups for coughs, colds and fever due to lack of child-resistant packaging, unintentional ingestion and poisoning hazards. CPSC: http://ht.ly/hmAsg

Direct link: http://www.cpsc.gov/en/Recalls/2013/Triaminic-and-Theraflu-Products-Recalled/

Additional information:
The US Consumer Product Safety Commission (“CPSC”) reports the child-resistant caps can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place. This poses a risk of unintentional ingestion and poisoning for the 24 variants of the two products included in this recall. These products contain Acetaminophen and Diphenhydramine, both of which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.

Please note: this is a joint recall with Health Canada.

CPSC recall number: 13-114
Recalls Direct RIN: 2013-1508

Novartis Cough & Cold Product Recall

Canada/Ottawa: Novartis recalls numerous Cough & Cold Products due to lack of child-resistant packaging hazard. HCSC: http://ht.ly/hlBoD

Direct link: http://hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2013/2013_16-eng.php

Additional information:
Health Canada (“HCSC”) reports the following Novartis brands are affected by this recall:

  • Jack & Jill
  • Triaminic
  • Neo Citran
  • Buckley’s

HCSC recall number: 2013-16
Recalls Direct RIN: 2013-1505

%d bloggers like this: